New World Order - global government

New World Order

This page is a place to park references to a "New World Order" (NWO) or "One World Government" (OWG), the New World System, global government...whatever name means one world CONTROL. As the "control" arm for a one world "government" would…

J&J halt Phase III clinical trial

On October 13, 2020, Johnson & Johnson became the second vaccine maker to halt phase III clinical trials while investigators probe whether a participant’s stroke may be linked to the vaccine..  AstraZeneca paused their trials a month earlier. On October 23, 2020, J&J announced it will resume it's clinical trails.  "After a thorough evaluation of a serious medical event experienced by one study participant, no clear cause has been identified...the Company has found no evidence that the vaccine candidate caused the event."

CDC to use V-SAFE, a new app system to actively monitor COVID-19 vaccines outside clinical trial setting

On September 22, 2020 the CDC's COVID-19 Vaccine Planning Unit (VPU) presented their plan, once the vaccines rolled out, to conduct active "enhanced safety monitoring for COVID-19 vaccines in early phase vaccination" through smartphone and email-based web surveys, in addition to VAERS. The CDC introduced the Vaccine Safety Assessment For Essential workers (V-SAFE) phone app at vaccine roll-out, initially intended for health workers, though was made available to the general public to download and register.   For the first week participants would get prompted to enter post vaccination information, then weekly up to [only] 6 weeks - this is called active surveillance. [2] The purpose of the V-SAFE app “is to rapidly characterize the safety profile of COVID-19 vaccines when given outside a clinical trial setting.” Data submitted to V-SAFE  is “collected, managed, and housed on a secure server by Oracle,” a private, third-party computer technology company who receives the data in deidentified form. [3] The US Vaccine Adverse Events Reporting System (VAERS) is "the US early warning safety monitoring system", co-managed by the CDC and FDA, with an established baseline yearly reporting rate. [1]  The management of vaccine safety has historical issues! By December 2021 the CDC refuse, through..> READ MORE

Eurosurveillance Corman-Drosten PCR paper published

On January 23, 2020 Christian Drosten and Victor Corman et al publish in Eurosurveillance , just 24 hrs after submission, their paper titled "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR" - the basis for PCR testing globally.  The paper was submitted only 11 days after genome sequence release on Jan 10, 2020, before anyone outside of China In acute respiratory infection, RT-PCR is routinely used to detect causative viruses from respiratory secretions....virus isolates or samples from infected patients have so far not become available to the international public health community." "We report here on the establishment and validation of a diagnostic workflow for 2019-nCoV screening and specific confirmation, designed in absence of available virus isolates or original patient specimens".

UN hold first ID2020 summit

On May 20, 2016 the United Nations held the first ID2020 summit in New York, which is now held annually. The United Nations recognizes "identity as a fundamental human right", and ID2020 is a strategic, global initiative launched in response to Sustainable Development Goal 16.9., with the aim "by 2030, provide legal identity to all, including birth registration" [1] "Together we will foster a global conversation and build a working coalition to identify and build the enabling conditions for the creation of a legal digital identity for all individuals at risk". The UN claims that one fifth of the worlds population is without a recognised legal ID which makes them "invisible to society and vulnerable to trafficking, prostitution, and child abuse." Then the ID2020 Alliance launched in 2017 as a global public-private partnership setting the future course of digital identity (ID), ensuring that digital identity is responsibly implemented and widely accessible, as they state no government, company or agency can solve this challenge alone. Its partners include Microsoft, the Rockefeller Foundation, Accenture, GAVI (a core partner of the WHO), UNICEF, the Bill & Melinda Gates Foundation and the World Bank. [2, 3]
Professor Norman Fenton

Professor Norman Fenton

Norman Fenton is Professor of Risk and Information Management at Queen Mary University of London and is also a Director of Agena, a company that specialises in risk assessment for critical systems.  Norman is a mathematician by training whose current…

Legislation allows FDA to be funded by Pharmaceutical giants

On September 22, 1992, the US Congress passed H.R.5952, the Prescription Drug User Fee Act (PDUFA), which was signed into law October 29, 1992.  This Act allowed the pharmaceutical sponsor to "fund the US Food and Drug Administration (FDA) directly through “user fees” intended to support the cost of swiftly reviewing drug applications. With the Act, the FDA moved from a fully taxpayer funded entity to one supplemented by industry money. The PDUFA fees collected have increased 30 fold—from around $29m in 1993 to $884m in 2016."  PDUFA fee schedule is renewed every five years. [1, 2, 3] New drugs have patents, which have a time limit before they expire, and research and development (R&D) costs cannot be recouped until a product gains regulatory approval.  The FDA estimated a 30 day delay could cost the drug sponsor $10 million, and the regulator already had a backlog of drugs awaiting approval.  A faster regulatory process was argued to be in the interest of the manufactures (lower cost to market), the regulator (fund more staff) and consumers (life saving drugs!). [1] Spurred on by the AIDS and Cancer epidemics a presidential advisory panel on drug approval reported on August 16, 1990 that..> READ MORE